A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

August 23, 2024

Study Completion Date

May 29, 2025

Conditions
Psoriasis
Interventions
DRUG

Deucravacitinib

Specified dose on specified days.

OTHER

Placebo

Specified dose on specified days.

Trial Locations (38)

10011

Local Institution - 0032, New York

10128

Local Institution - 0013, New York

14623

Local Institution - 0001, Rochester

20016

Local Institution - 0024, Washington D.C.

20850

Local Institution - 0018, Rockville

29407

Local Institution - 0019, Charleston

30078

Local Institution - 0020, Snellville

30331

Local Institution - 0037, Atlanta

33028

Riverchase Dermatology, Pembroke Pines

33134

Local Institution - 0016, Coral Gables

33511

Local Institution - 0027, Brandon

43209

Local Institution - 0005, Bexley

44124

Local Institution - 0012, Mayfield Heights

48326

Local Institution - 0010, Auburn Hills

48328

Local Institution - 0002, Waterford

60008

Local Institution - 0007, Rolling Meadows

60077

Local Institution - 0025, Skokie

62703

Local Institution - 0036, Springfield

70809

Local Institution - 0003, Baton Rouge

72117

Local Institution - 0015, North Little Rock

75034

Local Institution - 0028, Frisco

77433

Local Institution - 0029, Cypress

80111

Local Institution - 0030, Centennial

84095

Local Institution - 0008, South Jordan

84663

Local Institution - 0033, Springville

85006

Local Institution - 0006, Phoenix

85260

Local Institution - 0034, Scottsdale

89148

Local Institution - 0017, Las Vegas

89509

Local Institution - 0035, Reno

92103

Local Institution - 0022, San Diego

93309

Local Institution - 0004, Bakersfield

95815

Local Institution - 0009, Sacramento

98004

Local Institution - 0021, Bellevue

98012

Local Institution - 0031, Mill Creek

99202

Local Institution - 0014, Spokane

00727

Local Institution - 0040, Caguas

00985

Local Institution - 0038, Carolina

00917

Local Institution - 0039, San Juan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY